KZA
Click for more information
8.87% $1.34 kazia therapeutics limited

Kazia to Present Cantrixil Data

  1. Neyepudete22
    684 Posts.
    lightbulb Created with Sketch. 32
    clock Created with Sketch.
    25/03/19
    22:38
    Post #: 37879943
    Kazia Therapeutics Ltd (KZA) reported that it has been selected to present data from the Phase I study of Cantrixil in ovarian cancer at the American Association for Cancer Research (AACR) 2019 Annual Meeting, one of the top-tier academic conferences worldwide that brings together around 20,000 representatives from academia, industry, government and advocacy organisations from across the globe

    http://crweworld.com/article/news-provided-by-pr-newswire/1027702/kazia-to-present-on-cantrixil-at-american-association-for-cancer-research-aacr-2019-annual-meeting
    KZA Price at posting: 47.0¢ Sentiment: None Disclosure: Not Held
    Likes Created with Sketch. 14  Upvote
    lightbulb Created with Sketch. 1  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.